News Elementor

RECENT NEWS

Category: Drugs (Pharmaceuticals)

F.D.A. Nominee to Face Grilling Over Cutbacks and Policy Shifts

F.D.A. Nominee to Face Grilling Over Cutbacks and Policy Shifts

Dr. Marty Makary may face sharp questions from senators about whether he will defend the Food and Drug Administration against staff cutbacks and industry pressure on Thursday, although he is still expected to sail through his confirmation hearing to become the agency’s commissioner. Dr. Makary built his reputation as a contrarian in the medical field, […]
Read more
Florida Seeks Drug Prescription Data With Names of Patients and Doctors

Florida Seeks Drug Prescription Data With Names of Patients and Doctors

Florida’s insurance regulator has demanded an unusually intrusive trove of data on millions of prescription drugs filled in the state last year, including the names of patients taking the medications, their dates of birth and doctors they’ve seen. The Florida Office of Insurance Regulation in January sought this information from pharmacy benefit managers like UnitedHealth’s […]
Read more
Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy

Novo Nordisk Annual Sales Jump on Demand for Ozempic and Wegovy

Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, capped off a somewhat turbulent 2024, reporting profit and revenue on Wednesday that comfortably beat Wall Street expectations. But the drugmaker said it expected sales growth to slow in 2025, as competition increases. Novo Nordisk retains its title as Europe’s most valuable company, but its […]
Read more

TRENDING

Category: Drugs (Pharmaceuticals)

The US Media

The US Media is a dynamic online news platform delivering timely, accurate, and comprehensive updates across a range of topics, including politics, business, technology, entertainment, and sports. With a commitment to credible journalism, United News provides in-depth analyses, breaking news, and thought-provoking features, ensuring readers stay informed about global and local developments.

SUBSCRIBE US

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution